Tom P Freeman
Tom P Freeman
Senior Lecturer, Department of Psychology, University of Bath
Verified email at bath.ac.uk
Title
Cited by
Cited by
Year
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
M Di Forti, D Quattrone, TP Freeman, G Tripoli, C Gayer-Anderson, ...
The Lancet Psychiatry 6 (5), 427-436, 2019
3572019
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
CJA Morgan, G Schafer, TP Freeman, HV Curran
The British Journal of Psychiatry 197 (4), 285-290, 2010
3172010
Keep off the grass? Cannabis, cognition and addiction
HV Curran, TP Freeman, C Mokrysz, DA Lewis, CJA Morgan, LH Parsons
Nature Reviews Neuroscience 17 (5), 293-306, 2016
2952016
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
TP Freeman, AR Winstock
Psychological medicine 45 (15), 3181-3189, 2015
2202015
Cannabidiol attenuates the appetitive effects of Δ 9-tetrahydrocannabinol in humans smoking their chosen cannabis
CJA Morgan, TP Freeman, GL Schafer, HV Curran
Neuropsychopharmacology 35 (9), 1879-1885, 2010
2152010
New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
S Chandra, MM Radwan, CG Majumdar, JC Church, TP Freeman, ...
European archives of psychiatry and clinical neuroscience 269 (1), 5-15, 2019
2012019
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
CJA Morgan, C Gardener, G Schafer, S Swan, C Demarchi, TP Freeman, ...
Psychological medicine 42 (2), 391-400, 2012
1902012
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis …
C Hindocha, TP Freeman, G Schafer, C Gardener, RK Das, CJA Morgan, ...
European Neuropsychopharmacology 25 (3), 325-334, 2015
1542015
Can we make cannabis safer?
A Englund, TP Freeman, RM Murray, P McGuire
The Lancet Psychiatry 4 (8), 643-648, 2017
1252017
Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
TP Freeman, CJA Morgan, C Hindocha, G Schafer, RK Das, HV Curran
Addiction 109 (10), 1686-1694, 2014
1232014
Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’
TP Freeman, CJA Morgan, J Vaughn‐Jones, N Hussain, K Karimi, ...
Addiction 107 (4), 792-800, 2012
1192012
The neuropsychopharmacology of cannabis: A review of human imaging studies
MAP Bloomfield, C Hindocha, SF Green, MB Wall, R Lees, K Petrilli, ...
Pharmacology & therapeutics 195, 132-161, 2019
1162019
Medicinal use of cannabis based products and cannabinoids
TP Freeman, C Hindocha, SF Green, MAP Bloomfield
Bmj 365, 2019
1122019
No smoke without tobacco: a global overview of cannabis and tobacco routes of administration and their association with intention to quit
C Hindocha, TP Freeman, JA Ferris, MT Lynskey, AR Winstock
Frontiers in psychiatry 7, 104, 2016
992016
Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’hypotheses
W Lawn, TP Freeman, RA Pope, A Joye, L Harvey, C Hindocha, ...
Psychopharmacology 233 (19), 3537-3552, 2016
972016
Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom
C Hindocha, NDC Shaban, TP Freeman, RK Das, G Gale, G Schafer, ...
Drug and alcohol dependence 148, 165-171, 2015
932015
Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands
TP Freeman, P van der Pol, W Kuijpers, J Wisselink, RK Das, S Rigter, ...
Psychological medicine 48 (14), 2346-2352, 2018
852018
Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’and individually: a placebo-controlled trial
C Hindocha, TP Freeman, JX Xia, NDC Shaban, HV Curran
Psychological Medicine 47 (15), 2708-2719, 2017
852017
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
AM Freeman, K Petrilli, R Lees, C Hindocha, C Mokrysz, HV Curran, ...
Neuroscience & Biobehavioral Reviews 107, 696-712, 2019
832019
Increasing potency and price of cannabis in Europe, 2006–16
TP Freeman, T Groshkova, A Cunningham, R Sedefov, P Griffiths, ...
Addiction 114 (6), 1015-1023, 2019
832019
The system can't perform the operation now. Try again later.
Articles 1–20